Trial Profile
A Phase IIa Study of GnRH agonist (ISR48) for the Treatment of Antiretroviral Therapy (ART) Resistant HIV Patients
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 02 Apr 2018
Price :
$35
*
At a glance
- Drugs Triptorelin (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 02 Apr 2018 New trial record